However, accumulating evidence has shown that the activation of NF-κB in the majority of renal disorders, as well as in CKD, is always a damaging effect that promotes oxidative stress, fibrosis, and apoptosis [49,50]. This evidence concerns the gene NFKB1 and chronic kidney disease.